CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions to the fore and informing the patient community. This talk series will be hosted by Gary Petersen, our Myeloma talk...
We are excited to announce that CureTalks has launched a new format with a talk series on Covid -19 in collaboration with the University of Pennsylvania. The new format moves away from the standard CureTalks radio pattern and introduces the panel on video. The talk series...
Matching the right patient to the right trial remains the most challenging task in the success of any clinical trial. This Clinical Trials day, our partners WCG (WIRB-Copernicus Group) organized the first invite only roundtable to share how iConnect - our patient recruitment platform is...
October 2018 marks the 10th anniversary of TrialX Inc. and Applied Informatics Inc. Our journey officially began on 12th October, 2008, after we were approached by Google mentioning that they liked our hack for trial search on their big table. We were invited to be...
Time magazine named CAR-T cell therapy pioneer Dr Carl June of University of Pennsylvania in their 2018 TIME 100 annual list of the 100 most influential people in the world. We had the opportunity to talk to Dr Carl June at CureTalks about how this...
Without clinical trials we cannot expect to see any advancements in medicine; and to participate in one, patients need to be aware of ongoing trials. The National Cancer Institute (NCI) HINTS (Health Information Trends Survey, hints.cancer.gov) found that 34% of Americans have not heard of...
CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have highlighted adoptive immunotherapy with chimeric antigen receptor (CAR) T cells as the most important clinical cancer advance of the year. Released in...